Publication | Open Access
Assessment of <sup>18</sup>F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
241
Citations
26
References
2020
Year
This multicenter evaluation indicates a value of 18F-PI-2620 to differentiate suspected patients with PSP, potentially facilitating more reliable diagnosis of PSP.
| Year | Citations | |
|---|---|---|
Page 1
Page 1